China Issues Guidance on VAT Reduction for Certain Drugs
China issued guidance on its value-added tax “reduction policies” for certain anti-cancer and rare disease drugs, a Sept. 30 notice said, according to an unofficial translation. China said it will reduce VATs on those imported drugs by 3% and will…
Sign up for a free preview to unlock the rest of this article
Timely, relevant coverage of court proceedings and agency rulings involving tariffs, classification, valuation, origin and antidumping and countervailing duties. Each day, Trade Law Daily subscribers receive a daily headline email, in-depth PDF edition and access to all relevant documents via our trade law source document library and website.
allow “general VAT taxpayers” to “produce, sell, wholesale and retail” the drugs. The notice also contains instructions on how to declare the imports with Chinese customs and a list of drugs that qualify.